| Feature | Delirium | Dementia |
|---|---|---|
| Onset | Acute (hoursโdays) | Chronic (monthsโyears) |
| Course | Fluctuating (waxes and wanes) | Progressive, stable day-to-day |
| Attention | Impaired (cardinal feature) | Preserved until late stages |
| Consciousness | Altered (hyperalert or obtunded) | Clear until late stages |
| Reversibility | Reversible (treat the cause) | Irreversible (but delirium can be superimposed on dementia) |
| Letter | Cause | Workup |
|---|---|---|
| A | Alcohol (withdrawal or intoxication), acidosis | BAL, urine tox, ABG, CIWA |
| E | Electrolytes (Naโบ, Caยฒโบ, glucose, Mg), endocrine (thyroid, adrenal) | BMP, Ca, Mg, POโ, TSH, cortisol, glucose |
| I | Infection (UTI, pneumonia, meningitis, sepsis) | CBC, UA, CXR, blood cultures, LP if indicated |
| O | Oxygen (hypoxia, hypercarbia, CO poisoning) | ABG, SpOโ, CO level if suspected |
| U | Uremia, hepatic encephalopathy | BUN/Cr, ammonia, LFTs |
| T | Trauma, temperature (hypo/hyperthermia) | Head CT, core temp |
| I | Iatrogenic (medications -#1 modifiable cause) | Med review: benzos, opioids, anticholinergics, steroids, polypharmacy |
| P | Psychiatric (diagnosis of exclusion), post-ictal | Rule out organic causes first. EEG if concern for non-convulsive status |
| S | Stroke, seizure, space-occupying lesion | CT head, MRI, EEG |
| Drug | Dose | When | Notes |
|---|---|---|---|
| Haloperidol (Haldol) | 0.5โ2 mg IV/IM/PO q4โ6h PRN | Agitated delirium threatening safety (pulling lines, aggression) | No evidence it shortens delirium duration. Use lowest effective dose, shortest duration. Monitor QTc (hold if QTc > 500). Avoid in Parkinson's (worsens motor symptoms). |
| Quetiapine (Seroquel) | 25โ50 mg PO at bedtime | Sundowning, nocturnal agitation, ICU delirium | Lower EPS risk than haloperidol. Sedating. Preferred in Parkinson's and Lewy body dementia (less D2 blockade). Start 12.5โ25 mg in elderly. |
| Dexmedetomidine | 0.2โ1.5 mcg/kg/hr IV | ICU delirium (intubated patients) | MENDS, 2007: dex reduced delirium duration vs midazolam in ICU. SEDCOM, 2009: less delirium (54% vs 76.6%) and shorter extubation time vs midazolam. DahLIA, 2016: dex resolved agitated delirium faster and reduced ventilator time. No respiratory depression. Preferred ICU sedative for delirium. |
| Exception | Agent / Dose | Why Benzos Are Correct Here |
|---|---|---|
| Alcohol withdrawal delirium (DTs) Most common benzo indication in elderly delirium | Lorazepam 1โ2 mg IV q1โ2h symptom-triggered (CIWA), or diazepam 5โ10 mg IV loading. Prefer lorazepam in liver disease. | Benzos replace the GABA tone that alcohol was providing. Underdosing kills (seizures, aspiration). Haloperidol lowers seizure threshold and does NOT treat withdrawal. |
| Benzodiazepine withdrawal | Restart a long-acting benzo (diazepam or chlordiazepoxide) at equipotent dose, then taper by 10โ25% every 1โ2 weeks. | Abrupt discontinuation of chronic benzos causes a withdrawal delirium that mirrors DTs. Requires slow taper, not abstinence. |
| Catatonia (often mistaken for hypoactive delirium) Mutism, staring, waxy flexibility, posturing | Lorazepam 1โ2 mg IV/IM challenge (both diagnostic and therapeutic). If response, continue 1โ2 mg q4โ6h scheduled. | Catatonia responds rapidly to lorazepam. Antipsychotics can worsen or trigger malignant catatonia, so get the diagnosis right first. Always consider catatonia in a quiet, unresponsive elderly patient. |
| Seizure or non-convulsive status epilepticus (NCSE) | Lorazepam 2โ4 mg IV, then load anti-seizure med (levetiracetam, fosphenytoin). | Persistent post-ictal confusion or fluctuating delirium with no clear cause should trigger EEG. Benzos stop the seizure, ASM prevents recurrence. |
| Neuroleptic malignant syndrome (NMS) or serotonin syndrome | Lorazepam 1โ2 mg IV q4โ6h as adjunct to supportive care. | Benzos reduce rigidity and agitation. Primary treatment is stopping the offending agent and cooling; benzos buy time and reduce muscle breakdown. |
| Agent | Elderly Dose | When to Choose | Cautions |
|---|---|---|---|
| Haloperidol (Haldol) FIRST LINE | 0.25โ0.5 mg PO/IV/IM q4โ6h PRN. Max ~3 mg/24h in frail elderly. | Hyperactive agitation threatening safety (pulling lines, aggression). Non-Parkinsonian patient. | Check QTc before dosing, hold if > 500. EPS, akathisia. Contraindicated in Parkinson's and Lewy body dementia (precipitates motor crisis). |
| Quetiapine (Seroquel) DLB / PARKINSON'S | 12.5โ25 mg PO at bedtime, can give 12.5 mg q12h PRN. Start low, titrate slowly. | Parkinson's disease, Lewy body dementia, sundowning, nocturnal agitation. Less D2 blockade so fewer motor side effects. | Sedating (can cause daytime somnolence). Orthostatic hypotension in elderly. Still carries the FDA black box warning. |
| Risperidone (Risperdal) | 0.25โ0.5 mg PO BID PRN. | Alternative to haloperidol when oral route available. | EPS at higher doses. Orthostatic hypotension. Not preferred in Parkinson's / DLB. |
| Olanzapine (Zyprexa) | 2.5โ5 mg PO or IM q8โ12h PRN. | Refractory agitation, when oral route fails and IM needed. | Sedation, weight gain, anticholinergic effects at higher doses, orthostatic hypotension. |
| Dexmedetomidine ICU ONLY | 0.2โ1.5 mcg/kg/hr IV infusion. | ICU delirium, especially ventilated patients or when extubation is imminent. MENDS, 2007, SEDCOM, 2009, DahLIA, 2016. | Requires continuous monitoring. Bradycardia, hypotension. Not for floor patients. |
| Mimic | How to catch it in 60 sec | Why this is the first move |
|---|---|---|
| Hypoxia | SpOโ, RR, accessory muscle use | A hypoxic patient sedated with haldol stops fighting AND stops breathing. SpOโ before any sedative, no exceptions. |
| Hypoglycemia | Fingerstick | Looks identical to delirium. Missed โ seizure, anoxic injury, death. D50 1 amp IV solves it in 90 seconds. |
| Alcohol or BZD withdrawal | Tremor, HR, BP, diaphoresis, last-drink history, CIWA score | Haloperidol does NOT treat withdrawal AND lowers seizure threshold. Wrong drug here = grand mal seizure on the floor. |
| Urinary retention or fecal impaction | Bladder scan, suprapubic exam, rectal | A 1-liter bladder is a top cause of "sudden delirium" in older men. Straight-cath fixes it without a single milligram. |
| Uncontrolled pain | Grimacing, guarding, surgical site, fracture, ischemic limb. PAINAD scale if non-verbal. | Under-treated pain is the most common reversible trigger of post-op agitation. Antipsychotic without analgesic just snows a hurting patient. |
| Hypercapnia | COPD/OSA history, recent opioids, somnolence preceding agitation. VBG/ABG if suspected. | COโ narcosis presents as agitation BEFORE somnolence. Sedating accelerates the crash to intubation. |
| Acute intracranial event | Focal exam, recent fall, anticoagulation, asymmetric pupils, new headache | Anticoagulated patient with new agitation = non-contrast head CT before sedation. A sedated stroke patient masks the deficit. |
| NMS or serotonin syndrome | Rigidity, hyperreflexia (SS) or lead-pipe rigidity (NMS), fever, recent antipsychotic or serotonergic agent | BOTH contraindicate haldol. Stop offender, cool, supportive care; benzodiazepines are correct here, antipsychotics are not. See NMS vs Serotonin Syndrome. |
| Scenario | Drug | Dose | Why this one |
|---|---|---|---|
| Parkinson's disease or Lewy body dementia | Quetiapine (Seroquel) | 12.5โ25 mg PO; can repeat q12h | Least D2 blockade of the antipsychotics โ least extrapyramidal effect. Haldol can precipitate parkinsonian crisis or NMS in these patients. |
| QTc 470โ500 or other QT concern | Olanzapine (Zyprexa) | 2.5โ5 mg PO/IM (PO disintegrating available) | IM available when refusing PO, less QT effect than haldol at low doses. Anticholinergic at higher doses, so keep it low in elderly. |
| Need oral, haldol contraindicated for non-Parkinson's reason | Risperidone (Risperdal) | 0.25โ0.5 mg PO BID PRN | Solid PO option when IV access is fine and you need a lower-EPS-risk-than-haldol agent. Avoid in Parkinson's and DLB. |
| Drug | Dose | Onset | When to choose / cautions |
|---|---|---|---|
| Droperidol (Inapsine) FAST IV |
2.5 mg IV/IM, may repeat q15-30 min. Cap ~10 mg/24h on the wards. (5 mg in younger non-frail adults; 1.25 mg in the very elderly.) | IV 3-10 min IM 15-30 min |
Butyrophenone (same class as haldol) with faster IV onset and more sedation per milligram. Carries an FDA black box (2001) for QT prolongation and torsades based on older 25+ mg surgical-anesthesia and antiemetic doses; at modern 2.5-5 mg agitation doses with baseline EKG screening, recent ED literature (Calver 2015, Perkins 2015) shows safety profile comparable to haldol, and many EDs now use droperidol as the preferred parenteral antipsychotic for severe agitation. Pre-dose checks identical to haldol: EKG (QTc < 500), K, Mg. Same contraindications as haldol (Parkinson's, DLB, prior NMS). |
| Olanzapine (Zyprexa) IM SEDATION |
5-10 mg IM (Zydis ODT also available for cooperative PO refuser). Max 30 mg/24h. Cap at 10 mg single dose in older adults. | 15-45 min IM | More sedating than haldol or droperidol, useful when the dominant problem is the patient cannot rest. Do NOT combine with IM/IV lorazepam within 1 hour, FDA black box for cardiorespiratory depression and death (especially in elderly). Anticholinergic load at higher doses, hence the elderly cap. |
| Ziprasidone (Geodon) IM NON-PARKINSON ATYPICAL |
10-20 mg IM, may repeat q4h. Max 40 mg/24h. | 15-30 min IM | Useful when haldol is contraindicated for non-QT reasons (Parkinson's, prior NMS) and the patient is refusing PO. Less sedating than olanzapine, less anticholinergic. Caveat: ziprasidone has the highest QT-prolonging effect of the atypical antipsychotics, so it does NOT rescue you when QTc is the contraindication, the alternative for QT-prolonged patients is non-pharmacologic management plus level-of-care escalation. |
| Level-of-care escalation CALL FOR HELP |
Rapid response โ anesthesia โ step-down or ICU transfer | Immediate | If 2-3 antipsychotics across 60-90 min have failed, stop and call. The diagnosis is probably wrong (re-run the mimic sweep, consider NMS, serotonin syndrome, status epilepticus, ICH, sepsis), or the patient needs continuous dexmedetomidine 0.2-1.5 mcg/kg/hr in a monitored setting, the only reliably escalatory pharmacologic option beyond bolus antipsychotics, and not appropriate for a regular medical floor. DahLIA, 2016: dex resolves agitated delirium faster than placebo in ventilated patients. |
Patient: 78M with mild dementia (baseline MMSE 22), POD 2 from hip fracture repair, found pulling at IV lines, yelling at staff, trying to climb out of bed at 2 AM. Received morphine PCA and diphenhydramine for sleep.
Key findings: HR 108, BP 162/94, Temp 37.2ยฐC. Agitated, disoriented to place and time, unable to spell "WORLD" backwards. CAM positive. UA: positive for UTI. Medications: morphine, diphenhydramine (both high-risk).
Management:
Teaching point: Always remove offending medications (anticholinergics, benzodiazepines, opioids) before reaching for antipsychotics. The MIND Trial, 2018 showed antipsychotics do NOT treat delirium.
Patient: 82F with CHF and CKD, admitted for pneumonia 4 days ago. Nursing notes: "sleeping most of day, not eating." Intern documents "oriented x3" based on brief interaction.
Key findings: Drowsy, slow to respond. Unable to list months backwards (inattention). Does not know she is in the hospital. CAM positive. RASS -2. Medications: lorazepam 0.5 mg HS, metoclopramide.
Management:
Teaching point: Hypoactive delirium is far more common (70% of cases) but frequently missed because patients are quiet. It carries worse prognosis than hyperactive delirium. Screen every elderly patient daily with CAM.
Patient: 65M intubated for 4 days with ARDS from pneumonia. Nurse reports intermittent agitation and lethargy. RASS fluctuating between -1 and +2.
Key findings: CAM-ICU positive. Currently on propofol drip and fentanyl for sedation. No spontaneous breathing trial attempted today. Foley catheter and bilateral soft restraints in place.
Management:
Teaching point: The ABCDEF bundle reduces ICU delirium, ventilator days, and mortality. Every day of delirium in the ICU independently increases mortality by 10%. Dexmedetomidine is preferred over benzodiazepines for sedation.
See the Overview and Management tabs for topic-specific diagnostic evaluation.
| Drug | Dose | Route | Notes |
|---|---|---|---|
| Haloperidol (Haldol) | 0.5-1 mg, repeat q30-60 min PRN | IV/IM | Low-dose antipsychotic for acute agitation. Avoid if QTc >500 ms. Check ECG before and after. Not FDA-approved for delirium but widely used. |
| Quetiapine (Seroquel) | 12.5-50 mg PO BID-TID | PO | More sedating, useful for nighttime agitation. Lower EPS risk than haloperidol. Monitor QTc. |
| Dexmedetomidine (Precedex) | 0.2-1.5 mcg/kg/hr IV | IV | Alpha-2 agonist. ICU setting for intubated patients. Maintains arousability. Reduces delirium duration vs benzodiazepines. Risk: bradycardia, hypotension. |
| Benzodiazepines AVOID | - | - | WORSEN delirium in most cases. Exception: alcohol withdrawal delirium and benzodiazepine withdrawal -benzodiazepines are treatment of choice for these specific etiologies. |